Nutritional, Bioactive, and Therapeutic Potential of Senna alexandrina Leaf Extract: Anti-Inflammatory Effects and Enhanced Anti-Helicobacter pylori Activity in Combination with Omeprazole–Amoxicillin–Rifabutin Therapy

Senna alexandrina is recognized for its medicinal uses, yet its multi-target therapeutic potential remains insufficiently characterized. To the best of our knowledge, this is the first study to investigate the anti-inflammatory and anti-Helicobacter pylori activities of S. alexandrina leaf extract in combination with the omeprazole–amoxicillin–rifabutin regimen, commercially known as Talicia. The study further evaluates whether the extract enhances the antibacterial activity of this established H. pylori treatment. Bioactivity of a methanolic leaf extract from Al-Qassim, Saudi Arabia, was evaluated using membrane stabilization, broth microdilution checkerboard assays, butyrylcholinesterase (BChE) inhibition, MTT assays on WI-38 human fibroblasts, and HPLC profiling. The extract exhibited protection against hypotonicity-induced erythrocyte hemolysis (IC50 = 8.44 µg/mL) and bactericidal activity against H. pylori ATCC 43504 (MIC = 31.25 µg/mL; MBC = 62.50 µg/mL; MBC/MIC = 2.0). Combining the extract with Talicia yielded a Fractional Inhibitory Concentration Index (FICI) of 0.75, indicating an additive to weakly synergistic interaction (7.81 µg/mL extract and 8.00 µg/mL Talicia). HPLC identified rosmarinic acid (16.05 mg/g dry extract) and quercetin (15.90 mg/g dry extract) as primary polyphenols. The extract showed cell-free BChE inhibition (IC50 = 31.8 µg/mL) and low cytotoxicity on WI-38 fibroblasts under tested conditions (IC50 = 191.1 µg/mL). Overall, S. alexandrina leaf extract displays preliminary in vitro membrane-stabilizing, antibacterial, and cholinesterase-inhibitory activities, enhancing Talicia activity via additive interaction. These findings justify further mechanistic, pharmacokinetic, toxicological, and in vivo investigations before any therapeutic or clinical relevance can be proposed.

Authors

Institutions

Publication Details

Journal
Separations
Published
2026-10-29
DOI
https://doi.org/10.3390/separations13110315
Primary Topic
Medicinal Plant Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Nutritional, Bioactive, and Therapeutic Potential of Senna alexandrina Leaf Extract: Anti-Inflammatory Effects and Enhanced Anti-Helicobacter pylori Activity in Combination with Omeprazole–Amoxicillin–Rifabutin Therapy

Mansour Alblaji
3 links
Separations
Medicinal Plant Research
article

Nutritional, Bioactive, and Therapeutic Potential of Senna alexandrina Leaf Extract: Anti-Inflammatory Effects and Enhanced Anti-Helicobacter pylori Activity in Combination with Omeprazole–Amoxicillin–Rifabutin Therapy

Mansour Alblaji
article en

Abstract

Senna alexandrina is recognized for its medicinal uses, yet its multi-target therapeutic potential remains insufficiently characterized. To the best of our knowledge, this is the first study to investigate the anti-inflammatory and anti-Helicobacter pylori activities of S. alexandrina leaf extract in combination with the omeprazole–amoxicillin–rifabutin regimen, commercially known as Talicia. The study further evaluates whether the extract enhances the antibacterial activity of this established H. pylori treatment. Bioactivity of a methanolic leaf extract from Al-Qassim, Saudi Arabia, was evaluated using membrane stabilization, broth microdilution checkerboard assays, butyrylcholinesterase (BChE) inhibition, MTT assays on WI-38 human fibroblasts, and HPLC profiling. The extract exhibited protection against hypotonicity-induced erythrocyte hemolysis (IC50 = 8.44 µg/mL) and bactericidal activity against H. pylori ATCC 43504 (MIC = 31.25 µg/mL; MBC = 62.50 µg/mL; MBC/MIC = 2.0). Combining the extract with Talicia yielded a Fractional Inhibitory Concentration Index (FICI) of 0.75, indicating an additive to weakly synergistic interaction (7.81 µg/mL extract and 8.00 µg/mL Talicia). HPLC identified rosmarinic acid (16.05 mg/g dry extract) and quercetin (15.90 mg/g dry extract) as primary polyphenols. The extract showed cell-free BChE inhibition (IC50 = 31.8 µg/mL) and low cytotoxicity on WI-38 fibroblasts under tested conditions (IC50 = 191.1 µg/mL). Overall, S. alexandrina leaf extract displays preliminary in vitro membrane-stabilizing, antibacterial, and cholinesterase-inhibitory activities, enhancing Talicia activity via additive interaction. These findings justify further mechanistic, pharmacokinetic, toxicological, and in vivo investigations before any therapeutic or clinical relevance can be proposed.

SeparationsVol. 13(11)
Qassim University (SA)
Qassim University
Good health and well-being
Openalex Percentile: Top 15%
Medicinal Plant Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon